These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34219881)

  • 1. Quantitative Analysis of Galectin-3 Expression in Benign and Malignant Thyroid Nodules.
    Šamija I; Mateša N; Tadinac S; Jukić T
    Acta Clin Croat; 2020 Jun; 59(Suppl 1):25-31. PubMed ID: 34219881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galectin-3 and CD44v6 as markers for preoperative diagnosis of thyroid cancer by RT-PCR.
    Samija I; Mateša N; Lukač J; Kusić Z
    Diagn Mol Pathol; 2011 Dec; 20(4):233-41. PubMed ID: 22089351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galectin-3: presurgical marker of thyroid follicular epithelial cell-derived carcinomas.
    Saggiorato E; Aversa S; Deandreis D; Arecco F; Mussa A; Puligheddu B; Cappia S; Conticello S; Papotti M; Orlandi F
    J Endocrinol Invest; 2004 Apr; 27(4):311-7. PubMed ID: 15233548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HMGA2 Gene Expression in Fine-needle Aspiration Samples of Thyroid Nodules as a Marker for Preoperative Diagnosis of Thyroid Cancer.
    Šamija I; Mateša N; Kožaj S; Majstorović I; Bolanča A; Kusić Z
    Appl Immunohistochem Mol Morphol; 2019 Jul; 27(6):471-476. PubMed ID: 29406334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of galectin-3 in fine-needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasms.
    Inohara H; Honjo Y; Yoshii T; Akahani S; Yoshida J; Hattori K; Okamoto S; Sawada T; Raz A; Kubo T
    Cancer; 1999 Jun; 85(11):2475-84. PubMed ID: 10357421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular classification of thyroid nodules by cytology.
    Pagedar NA; Chen DH; Wasman JK; Savvides P; Schluchter MD; Wilhelm SM; Lavertu P
    Laryngoscope; 2008 Apr; 118(4):692-6. PubMed ID: 18094649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galectin-3 and CD44v6 positivity by RT-PCR method in fine needle aspirates of benign thyroid lesions.
    Matesa N; Samija I; Kusić Z
    Cytopathology; 2007 Apr; 18(2):112-6. PubMed ID: 17397496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The significance of Galectin-3 expression in the immunocytochemical evaluation of thyroid fine needle aspiration cytology.
    Ersoz S; Sert H; Yandi M; Erem C; Mungan S; Ersoz HO; Cobanoglu U; Hacihasanoglu A
    Pathol Oncol Res; 2008 Dec; 14(4):457-60. PubMed ID: 18415710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic utility of galectin-3 in aspirates of thyroid follicular lesions.
    Kim MJ; Kim HJ; Hong SJ; Shong YK; Gong G
    Acta Cytol; 2006; 50(1):28-34. PubMed ID: 16514837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galectin-3 and oncofetal-fibronectin expression in thyroid neoplasia as assessed by reverse transcription-polymerase chain reaction and immunochemistry in cytologic and pathologic specimens.
    Giannini R; Faviana P; Cavinato T; Elisei R; Pacini F; Berti P; Fontanini G; Ugolini C; Camacci T; De Ieso K; Miccoli P; Pinchera A; Basolo F
    Thyroid; 2003 Aug; 13(8):765-70. PubMed ID: 14558920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Significance of galectin-3 and CD44v6 expression in differential diagnosis of thyroid nodules].
    Wang LH; Zhao YJ; Wang XY; Yuan P; Xu WQ; Xiao JC; Xu JP; Luo BR
    Zhonghua Zhong Liu Za Zhi; 2005 Sep; 27(9):547-50. PubMed ID: 16438854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study.
    Bartolazzi A; Orlandi F; Saggiorato E; Volante M; Arecco F; Rossetto R; Palestini N; Ghigo E; Papotti M; Bussolati G; Martegani MP; Pantellini F; Carpi A; Giovagnoli MR; Monti S; Toscano V; Sciacchitano S; Pennelli GM; Mian C; Pelizzo MR; Rugge M; Troncone G; Palombini L; Chiappetta G; Botti G; Vecchione A; Bellocco R;
    Lancet Oncol; 2008 Jun; 9(6):543-9. PubMed ID: 18495537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human telomerase reverse transcriptase (hTERT) gene expression in FNA samples from thyroid neoplasms.
    Liou MJ; Chan EC; Lin JD; Liu FH; Chao TC
    Cancer Lett; 2003 Mar; 191(2):223-7. PubMed ID: 12618337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Application value of fine needle aspiration and cell block in preoperative diagnosis of thyroid cancer and discrimination of follicular tumor].
    Fang Q; Cai C; Chen H
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Aug; 50(8):668-72. PubMed ID: 26696207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum galectin-1 and galectin-3 levels in benign and malignant nodular thyroid disease.
    Saussez S; Glinoer D; Chantrain G; Pattou F; Carnaille B; André S; Gabius HJ; Laurent G
    Thyroid; 2008 Jul; 18(7):705-12. PubMed ID: 18630998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical expression of HBME-1 and galectin-3 in the differential diagnosis of follicular-derived thyroid nodules.
    Abd-El Raouf SM; Ibrahim TR
    Pathol Res Pract; 2014 Dec; 210(12):971-8. PubMed ID: 25041837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The expression of galectin-3 in nodular thyroid goitre].
    Chen WJ; Yu MH; Xu Y; Shen J
    Zhonghua Nei Ke Za Zhi; 2006 Jun; 45(6):452-5. PubMed ID: 16831319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression and clinical significance of galectin-3 in well-differentiated thyroid carcinoma].
    Ouyang D; Chen FJ; Wei MW; Yang AK; Chen ZQ; Li QL; Chen YF
    Ai Zheng; 2005 Nov; 24(11):1367-71. PubMed ID: 16552965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galectin-3 does not reliably distinguish benign from malignant thyroid neoplasms.
    Mehrotra P; Okpokam A; Bouhaidar R; Johnson SJ; Wilson JA; Davies BR; Lennard TW
    Histopathology; 2004 Nov; 45(5):493-500. PubMed ID: 15500653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galectin-3, a marker of well-differentiated thyroid carcinoma, is expressed in thyroid nodules with cytological atypia.
    Coli A; Bigotti G; Zucchetti F; Negro F; Massi G
    Histopathology; 2002 Jan; 40(1):80-7. PubMed ID: 11903601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.